Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers

Michael J. Curtis, Steve Alexander, Giuseppe Cirino, James R. Docherty, Christopher H. George, Mark A. Giembycz, Daniel Hoyer, Paul A. Insel, Angelo A. Izzo, Yong Ji, David J. MacEwan, Christopher G. Sobey, S. Clare Stanford, Mauro M. Teixeira, Sue Wonnacott, Amrita Ahluwalia

Research output: Contribution to journalEditorial

468 Citations (Scopus)

Abstract

This article updates the guidance published in 2015 for authors submitting papers to British Journal of Pharmacology (Curtis et al., 2015) and is intended to provide the rubric for peer review. Thus, it is directed towards authors, reviewers and editors. Explanations for many of the requirements were outlined previously and are not restated here. The new guidelines are intended to replace those published previously. The guidelines have been simplified for ease of understanding by authors, to make it more straightforward for peer reviewers to check compliance and to facilitate the curation of the journal's efforts to improve standards.

Original languageEnglish
Pages (from-to)987-993
Number of pages7
JournalBritish Journal of Pharmacology
Volume175
Issue number7
Early online date9 Mar 2018
DOIs
Publication statusPublished - 1 Apr 2018

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers'. Together they form a unique fingerprint.

Cite this